Financials
- Financial year
- 2025
- Turnover
- €358.3m
- Profit
- €3.7m
- Liquidity
- 1.63
Turnover▲ 6.5%
Net result
20182025
Summary
Pfizer has been active since 1954 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show a net result of €3.7m. Equity remains stable across the filed financial years (±2.2% per year). Its net result ranks better than 94% of 6,074 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.5% (very low).
Overview
Activity
Wholesale of pharmaceutical and medical goods
NACE 46460Manufacture of basic pharmaceutical products and pharmaceutical preparations NACE 21201
4th largest employer in Elsene, Wholesale and retail trade sector3 sites
Size
€358.3mturnover 2025
- Staff
- 297 FTE
- Profit
- €3.7m
Financial health
- Bankruptcy probabilitywithin 12 months
- 0.5%
Too few figures to score
Structure
- Parent
- PFIZER INC.
- Laurence EinsweilerDirector
- Réginald DecraeneManaging director
- Kathleen CommersDirector
2025 accounts 28 days early
Signalsraises riskEigen vermogen niet neergelegdLiquidity: current ratio 1.63, cash €23.9mlowers riskSize: turnover €358.3m, 297 FTE, total assets €377.4mFounded in 1954neutralLatest accounts filed on timeShow the evidence
Bankruptcy probability
No current score
Insufficient figures
A score requires measurable solvency, liquidity and profitability. Missing figures are not a judgement about the company.
Bankruptcy probability, 12 months
0.5%
Very low
0%0.5%1.5%4%10%≥ 25%
About 5 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 0.5%
12-2024: 0.5%● unchanged vs 11-2024
01-2025: 0.5%● unchanged vs 12-2024
02-2025: 0.5%● unchanged vs 01-2025
03-2025: 0.5%● unchanged vs 02-2025
04-2025: 0.5%● unchanged vs 03-2025
05-2025: 0.5%● unchanged vs 04-2025
06-2025: 0.5%● unchanged vs 05-2025
07-2025: 0.5%● unchanged vs 06-2025
08-2025: 0.5%● unchanged vs 07-2025
09-2025: 0.5%● unchanged vs 08-2025
10-2025: 0.5%● unchanged vs 09-2025
11-2025: 0.5%● unchanged vs 10-2025
12-2025: 0.5%● unchanged vs 11-2025
01-2026: 0.4%▼ -0.1 percentage points vs 12-2025
02-2026: 0.4%● unchanged vs 01-2026
03-2026: 0.4%● unchanged vs 02-2026lowest value
04-2026: 0.4%● unchanged vs 03-2026
05-2026: 0.4%● unchanged vs 04-2026
06-2026: 0.6%▲ +0.2 percentage points vs 05-2026highest value
07-2026: 0.5%▼ -0.1 percentage points vs 06-2026
08-2026: 0.5%● unchanged vs 07-2026
09-2026: 0.5%● unchanged vs 08-2026
10-2026: 0.5%● unchanged vs 09-2026
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 30-11-2025 was due by 30-06-2026 and was filed on 02-06-2026, 28 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
28 days early
2024
38 days early
2023
40 days early
2022
38 days early
2021
29 days early
2020
30 days early
2019
1 day early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 29 days before the deadline; the sector median (NACE 46) for financial year 2024 is 3 days before the deadline, and 39% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 30-11-2026 and is due by 30-06-2027. Nothing is late today. The company usually files around 23 May (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
25-10-2026 today30-11-2026 year end30-06-2027 deadline
- Resignations: Guy Van den Meersche (director)…Appointment: Kathleen Commers (director) ·…
- Annual accounts filedfinancial year 2025 · full…
- Resignations & appointmentsPower of attorney
Key points
- Caution: Result fell in 2025from €23.2m to €3.7m ▼ 84.2% View
- Caution: Board changedlatest change 01-07-2026 · 3 in office 2 joined · 3 left View
- Positive: Among the best 7% on net resultsector median €112,347 · 6,074 companies €3.7m View
- Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
- Positive: 8 profitable years in a rowprofit 2025: €3.7m 8 years View
- Controlled by PFIZER INC.ultimately: PFIZER INTERNATIONAL INC parent View
- Active since 1954founded 01-02-1954 72 years View
By topic
Board & ownership
- Board
- 3 members
- Parent
- PFIZER INC.
- Laurence EinsweilerDirector
- Réginald DecraeneManaging director
- Kathleen CommersDirector
Network & group
- Group
- PFIZER INTERNATIONAL INC
- Connected companies
- 2
- Mergers and asset contributions
- 4
Timeline
- Events
- 108
- Since
- 1977
- Next accounts
- by 30-06-2027
- 19-01-2026Resignation: David Lepoittevin (director and managing director)
- 30-11-2025Weakest financial year
- 26-06-2025Reappointments: Laurence Einsweiler (director) and KPMG Réviseurs…
Company details
- Sites
- 3
- Legal form
- Public limited company
- Activity
- Wholesale of pharmaceutical and medical goodsNACE 46460
- Founded
- 01-02-1954
- Year ends
- 30-11
- Peppol
- Reachable for e-invoices
Articles of association
- Provisions read
- 3
- Who signs
- Two directors jointly
- Purpose
- “La société a pour objet la fabrication et le commerce sous toutes ses formes, en ce y…” (deed in French)
Key facts about Pfizer
- What is the company number of Pfizer?
- 0401.994.823. In Belgium the VAT number is the company number with BE in front: BE 0401.994.823.
- Where is Pfizer based?
- The registered office is at Pleinlaan 17, 1050 Elsene.Company details
- What does Pfizer do?
- According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
- What is the legal form of Pfizer?
- Public limited company (NV).
- When was Pfizer founded?
- On 01-02-1954.
- Is Pfizer still active?
- Yes, Pfizer is an active enterprise in the KBO register.
- How many employees does Pfizer have?
- On average 297 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of Pfizer?
- €358.3m in financial year 2025, according to the filed annual accounts.
- Is Pfizer profitable?
- In financial year 2025, Pfizer made a profit of €3.7m.
- Where can I find the annual accounts of Pfizer?
- Pfizer filed 50 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Pfizer due?
- By 30-06-2027, for financial year 2026.Timeline
Companies related to Pfizer
Comparable companies
- SIEMENS HEALTHCAREDilbeek
- Terumo BCT EuropeZaventem
- JOHNSON & JOHNSON MEDICALMachelen (Brab.)
- Medtronic BelgiumJette
- CENTRE EUROPEEN DE REPARTITION PHARMACEUTIQUEAnderlecht
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Is the workforce growing, and do people stay?Employer check Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What support did similar companies receive that this one did not?Subsidies
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.